Research in Gene Therapy
Dr. Michael Nishimura, vice-chairman for research in the Department of Surgery, discusses his research in the area of gene therapy. He explains how research in genetic modification of lymphocytes is being conducted to develop exciting new treatments for cancer patients. While clinical trials related to this research are not currently being conducted at MUSC, Dr. Nishimura is working to make this a reality. Dr. Nishimura also provides some examples of the types of cancers most likely to be treated by means of gene therapy in the near future. (Source: MUSC Cancer Podcast)
Source: MUSC Cancer Podcast - October 1, 2014 Category: Cancer & Oncology Authors: Medical University of South Carolina Source Type: podcasts
Listen to The Lancet: 16 January
Robert MacLaren discusses how gene therapy improves eyesight in people born with choroideremia. (Source: Listen to The Lancet)
Source: Listen to The Lancet - January 16, 2014 Category: Journals (General) Authors: The Lancet Source Type: podcasts
The Lancet: January 16, 2014
Robert MacLaren discusses how gene therapy improves eyesight in people born with choroideremia. (Source: Listen to The Lancet)
Source: Listen to The Lancet - January 16, 2014 Category: General Medicine Authors: The Lancet Source Type: podcasts
Understanding Advances in Gene Therapy
Could a blood cancer patient's own immune cells soon be used to fight their cancer? In chimeric antigen receptor (CAR) gene therapy, T-cells are taken from a patient and genetically engineered to targ...
Author: patientpower
Added: 12/18/2013 (Source: Oncology Tube)
Source: Oncology Tube - December 19, 2013 Category: Cancer & Oncology Source Type: podcasts
TWiV 212: Apocalypse TWiV 122112 212
Hosts: Vincent Racaniello, Rich Condit, Alan Dove, and Kathy Spindler
The TWiVerers answer listener email about genetically modified chickens, a hendra vaccine for horses, online education, curing color blindness, Roosevelt and polio, Th cells, and much more.
Links for this episode:
TWiV 116: Cocaine, colonies, and chickens
Glofish
Recombinant Hendra vaccine
Gene therapy for color blindness (Nature)
FDR, polio, and Guillain-Barré
Transcript of TWiV 197: Philip Marcus (pdf)
TWiV 10: Bats, elephants, and AIDS
TWiM 6: Phage therapy
TWiP 47: For whom the trich tolls
Vir...
Source: This Week in Virology - MP3 Edition - December 24, 2012 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Archives of Ophthalmology 2012-01-09, Vol. 130, No. 1, Author Interview
Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 9, 2012 Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years
Interview with Samuel G. Jacobson, MD, PhD, author of Gene Therapy for Leber Congenital Amaurosis Caused by RPE65 Mutations: Safety and Efficacy in 15 Children and Adults Followed Up to 3 Years (Source: JAMA Specialty Journals Author Interviews)
Source: JAMA Specialty Journals Author Interviews - January 9, 2012 Category: General Medicine Authors: The JAMA Network Source Type: podcasts
The Lancet: November 06, 2009
Jean Bennett discusses the phase I study of gene therapy for Leber's congenital amaurosis. (Source: Listen to The Lancet)
Source: Listen to The Lancet - November 6, 2009 Category: General Medicine Authors: The Lancet Source Type: podcasts
The Lancet: June 22, 2007
Matthew During, author of a phase I study of gene therapy in the treatment of Parkinson's disease dicusses the study, designed to assess safety and tolerability, shows encouraging early results for the treatment of Parkinson's disease and other neurodegenerative disorders. (Source: Listen to The Lancet)
Source: Listen to The Lancet - June 22, 2007 Category: General Medicine Authors: The Lancet Source Type: podcasts
First gene therapy cancer treatment
(Source: MedlinePlus: NLM Director's Comments)
Source: MedlinePlus: NLM Director's Comments - May 15, 2006 Category: Databases & Libraries Authors: National Library of Medicine Source Type: podcasts
